INTRODUCTION
RNA metabolism relies on the dynamic interplay of RNAs with RNA-binding proteins (RBPs) forming ribonucleoprotein complexes, which control RNA fate from synthesis to decay (Glisovic et al., 2008) . Due to their central role in cell biology, it is unsurprising that mutations in RBPs underlie numerous hereditary diseases (Castello et al., 2013a; Lukong et al., 2008) .
Many RBPs are modular, built from a limited pool of RNAbinding domains (RBDs), including the RNA recognition motif (RRM) and other canonical RBDs (Lunde et al., 2007) . These domains have been characterized biochemically and structurally, furthering our understanding of protein-RNA interactions. The identification of unorthodox RBPs lacking canonical RBDs expands the scope of physiologically important protein-RNA interactions (e.g., Jia et al., 2008) .
System-wide approaches to identify RBPs have recently been developed, including immobilization of RNA probes (Butter et al., 2009) or proteins (Scherrer et al., 2010; Tsvetanova et al., 2010) , followed by in vitro selection of their interaction partners. These experiments identified numerous proteins previously unknown to bind RNA. While informative, in vitro protein-RNA interactions may arise non-physiologically from the electrostatic properties of RNA. To address this limitation, in vivo UV crosslinking has been used to covalently stabilize native protein-RNA interactions occurring in living cells. After cell lysis, proteins covalently bound to polyadenylated [poly(A)] RNAs are isolated by oligo(dT) selection and identified by quantitative mass spectrometry (Baltz et al., 2012; Castello et al., 2012) . This approach (named RNA interactome capture) identified over a thousand RBPs in HeLa and HEK293 cells, hundreds of which were previously unknown to bind RNA. Subsequently, similar data sets were obtained from mouse embryonic stem cells, Saccharomyces cerevisiae, and Caenorhabditis elegans (Beckmann et al., 2015; Kwon et al., 2013; Matia-Gonzá lez et al., 2015; Mitchell et al., 2013) , confirming earlier findings and further uncovering the repertoire of RBPs.
Several of the unorthodox RBPs identified in these studies have been characterized for their physiological roles in RNA biology. These include metabolic enzymes (Beckmann et al., 2015) , regulators of alternative splicing Tejedor et al., 2015) , the E3 ubiquitin ligase TRIM25 (Choudhury et al., 2014) , or the FAST kinase domain-containing protein 2 (FASTKD2) (Popow et al., 2015) . However, the RNAbinding regions of these unorthodox RBPs remain largely unknown.
To identify the interaction sites of such proteins with RNA, UV crosslinking followed by extensive RNase treatment has been used to detect the peptide mass shift induced by the crosslinked RNA remnant via mass spectrometry (Schmidt et al., 2012) . While conceptually simple, the mass heterogeneity of the nucleotide remnant has rendered this approach challenging in practice. Some RBDs have been characterized in vitro using this approach (reviewed in Schmidt et al., 2012) , and a sophisticated algorithm allowed assignment of 257 binding sites from 124 proteins in yeast (Kramer et al., 2014) . While informative, this data (legend continued on next page) set is strongly enriched for interactions mediated by RRMs, because the challenging identification of peptides with aberrant mass spectra requires both abundance and high crosslinking efficiency for detection. Nonetheless, 10% of the identified interaction sites mapped to non-canonical RBDs, supporting the existence of unanticipated modes of RNA binding. Here, we develop and exploit RBDmap as a method for the in vivo identification of RBDs on a proteome-wide scale. We identified 1,174 high-confidence RNA-binding sites in 529 RBPs from HeLa cells, generating an unprecedented atlas of RNA-binding architectures in vivo.
RESULTS AND DISCUSSION

Proteome-wide Mapping of RBDs by RBDmap
To define how RBPs bind to RNA in living cells, we extended RNA interactome capture (Castello et al., 2013b) by addition of an analytical protease digestion step followed by a second round of oligo(dT) capture and mass spectrometry ( Figure 1A ). First, UV light is applied to cell monolayers to covalently stabilize native protein-RNA interactions taking place at ''zero'' distance (Pashev et al., 1991) . While UV exposure using dosages exceeding those used here can potentially promote protein-protein crosslinking (Davidenko et al., 2016; Suchanek et al., 2005) , we could not detect such crosslinks under our conditions, evidenced by the lack of UV-dependent, high molecular weight complexes in RNase-treated samples (Figures S1A and S4A; Strein et al., 2014) .
Proteins crosslinked to poly(A) RNA are isolated using oligo(dT) magnetic beads and purified by stringent washes that include 500 mM LiCl and chaotropic detergents (0.5% LiDS), efficiently removing non-covalent binders (Castello et al., 2012 (Castello et al., , 2013b . After elution, RBPs are proteolytically digested by either LysC or ArgC. These proteases were selected as best suited for RBDmap by an in silico simulation of their predicted cleavage patterns of known HeLa RBPs (Castello et al., 2012) and their compatibility with subsequent tryptic digestion ( Figure S1B ). Analysis by mass spectrometry (MS) of LysC-and ArgC-treated samples revealed an excellent match with the in silico predictions, as reflected by the low number of missed cleavages ( Figures 1B and 1C) . The extensive proteolysis of HeLa RBPs is achieved without compromising RNA integrity . The average peptide length after LysC and ArgC treatment is $17 amino acids, which defines the resolution of RBDmap ( Figure 1C ). Note that the extensive protease treatment disrupts protein integrity, and thus protein-protein complexes that might have withstood the experimental conditions will be released into the supernatant.
We collected an input sample aliquot after UV irradiation, oligo(dT) selection, and protease digestion, which in principle should reflect the RNA interactome ( Figure 1A) . When compared to a non-irradiated specificity control, the resulting high-confidence RBPs overlap 82% with the previously published human RNA interactomes (Baltz et al., 2012; Beckmann et al., 2015; Castello et al., 2012 ). This high concordance shows that LysC and ArgC treatments are fully compatible with the RNA interactome capture protocol. The remaining two thirds of the LysC or ArgC-treated samples were subjected to a second round of oligo(dT) purification leading to two peptide pools ( Figure 1A ): (1) peptides released from the RNA into the supernatant, and (2) peptides remaining covalently bound to the RNA, representing the RNA-binding sites of the respective RBPs. Importantly, subsequent tryptic digestion of the RNA-bound LysC/ArgC fragments yields two classes of peptides: the portion that still remains crosslinked to the RNA (X-link) and its neighboring peptides (N-link) ( Figure 1A ). While the directly crosslinked peptides (X-link) are difficult to identify due to the heterogeneous mass shift induced by the residual nucleotides (Kramer et al., 2014; Schmidt et al., 2012) , the native peptides adjacent to the crosslinking site (N-link) can be identified by standard MS and peptide search algorithms. The original RNA-bound region of the RBP (i.e., RBDpep; Figure 1A ), which includes both the crosslinked peptide (X-link) and its unmodified neighboring peptides (N-link), is then re-derived in silico by extending the MS-identified peptides to the two nearest LysC or ArgC cleavage sites.
Analysis of the RNA-bound and released fractions by quantitative proteomics shows high correlation of the resulting peptide intensity ratios between independent biological replicates. These ratios follow a bimodal distribution with one mode representing the released peptides (gray) and the other the RNAbound ones (red; Figures 1E and S1F). We detected 909 and 471 unique N-link peptides as significantly enriched in the RNA-bound fractions of LysC-or ArgC samples, respectively (1% false discovery rate, FDR) ( Figure S1G ). Notably, computed RNA-bound/released peptide intensity ratios also correlate between the LysC and ArgC data sets ( Figure 1F ), supporting the robustness of the workflow. Due to their different specificities, each protease also contributes unique 1% FDR RBDpeps to the complete peptide superset ( Figure S1G ), covering 529 RBPs that highly overlap with human RNA interactomes (Figure 1G) (Baltz et al., 2012; Beckmann et al., 2015; Castello et al., 2012) . Proteins within the RBDmap data set range from low to high abundance ( Figure S1H ), following a similar distribution as the input fraction and the HeLa RNA interactome (Castello et al., 2012) . Thus, RBDmap is not selective for highly abundant proteins. There were 154 additional RBPs that were identified here, helped by the reduction of sample complexity and of experimental noise by the additional proteolytic step and the second oligo(dT) capture. In agreement with this explanation, the relative abundance of corresponding RBDpeps is higher in the RNA-bound fractions than in the ''input'' samples ( Figures  1H and S1I) . Thus, RBDmap detects RNA-binding regions within hundreds of RBPs in one approach, even if it does not cover all RBPs identified by RNA interactome capture ( Figure 1G ). Proteins will be missed by RBDmap when (1) binding to nonpolyadenylated RNAs, (2) displaying low crosslinking efficiency, (3) interacting with the phospho-sugar backbone, but not the nucleotide bases, or (4) lacking suitable cleavage sites for trypsin within the LysC and ArgC proteolytic fragments and hence lacking MS-identifiable N-link peptides. Thus, the distribution of arginines (R) and lysines (K) will influence whether a given RBP can be studied by RBDmap, and we used two different proteases to maximize the identification of RBDpeps.
About half of the RBPs covered by RBDpeps harbor well-established RBDs and play known functions in RNA biology, reflected by a strong and significant enrichment of RNA-related protein domains and biological processes comparable to the HeLa RNA interactome (Figures 1I and S1J) . Note that the reduced RBP coverage of RBDmap compared to RNA interactome capture equally affects both well-established and unorthodox RBPs ( Figures 1I and S1J ).
RBDmap ''Rediscovers'' Classic RBDs Interestingly, RNA-bound and released proteolytic fragments display distinct chemical properties. Released peptides are rich in negatively charged and aliphatic residues, which are generally underrepresented in RNA-binding protein surfaces (Figures 2A, 2B , and S2A). Conversely, RBDpeps are significantly enriched in amino acids typically involved in protein-RNA interactions, including positively charged and aromatic residues. These data show that the chemical properties of the RBDpeps resemble those expected of bona fide RNA-binding surfaces. As a notable exception, glycine (G) is enriched in RBDpeps, but depleted from protein-RNA interfaces derived from available structures (Figures 2A and 2B ). Flexible glycine tracks can contribute to RNA binding via shape-complementarity interactions as described for RGG boxes (Phan et al., 2011) . Hence, lack of glycine at binding sites of protein-RNA co-structures reflects the technical limitations of crystallographic studies regarding disordered protein segments.
Validating the RBDmap data, classical RBDs such as RRM, KH, cold shock domain (CSD), and Zinc finger CCHC, are strongly enriched in the RNA-bound fraction ( Figure 2C ). This enrichment can also be appreciated at the level of individual protein maps . To evaluate the capacity of RBDmap to identify bona fide RBDs, we focused on RBPs that harbor at least one classical RBD (as listed in Lunde et al., 2007) . MS-identified peptides from these proteins were classified as ''within'' or ''outside'' a classical RBD, according to their position within the proteins' architecture ( Figure 2E ). The relative fraction of peptides within versus outside of the RBD was then plotted for each possible RNA-bound/released intensity ratio ( Figure 2F ). Correct re-identification of classical RBDs would lead to an ascending line (i.e., within/outside ratios should grow in parallel to the RNA-bound/release ratios; Figure 2E ), while a random distribution of peptides within and outside of classical RBDs would yield a horizontal line (i.e., within/outside ratios do not vary in accordance with the RNA-bound/released ratios; Figure 2E ). As shown in Figure 2F , the relative fraction of peptides mapping within classical RBDs increases in parallel with the RNA-bound/released ratios. Thus, RBDmap correctly assigns RNA-binding activity to well-established RBDs.
Unexpected initially, helicase domains are underrepresented in the RNA-bound fraction ( Figure 2C ). However, the high number of released helicase peptides likely reflects (1) the transitory and dynamic interactions that helicases establish with RNA, (2) the large protein segments of the domain situated far from the RNA, and (3) the predominance of interactions with the phospho-sugar backbone over nucleotide bases ( Figures S2C-S2E ) (Bono et al., 2006) . Nevertheless, high-confidence RBDpeps are found at the exit of the helicase tunnel, as discussed below ( Figures S2C-S2E ).
High-Resolution Determination of RNA-Binding Sites
For direct validation of the RBDmap data, we selected all those RBPs for which protein-RNA co-structures are available within the Protein Data Bank (PDB) repository. These were ''digested'' in silico with either LysC or ArgC, and the predicted proteolytic fragments were considered as ''proximal'' to RNA when the distance to the closest RNA molecule is 4.3 Å or less; otherwise, they were categorized as non-proximal ( Figure 3A) . About half of all LysC and ArgC fragments are proximal to RNA by this criterion, reflecting that many RBP structures are incomplete and focused on the RBDs (average protein coverage $50%). By contrast, 70.3% (LysC) and 81% (ArgC), respectively, of RBDpeps qualify as proximal, showing that RBPmap highly significantly enriches for peptides in close proximity to the RNA ( Figure 3A ). Several factors suggest that the pool of peptides classified as proximal in the analyzed structures even underestimates the performance of RBDmap: (1) in several structures of RBPs that harbor two or more RBDs, only one of the RBDs displays the interaction with RNA (e.g., PDB 3NNC) (Teplova et al., 2010) . At least in some of these cases, structures lack RNA contacts of RBDs that likely occur in vivo. (2) Proteins are normally co-crystallized with short nucleic acids (5 to 8 nucleotides), and their physiological RNA partners likely establish additional interactions with the RBP. (3) RNA-protein co-structures usually reflect one interaction state, while protein-RNA interactions are typically more dynamic in vivo (Ozgur et al., 2015; Safaee et al., 2012) .
RBDmap also correctly assigns RNA-binding regions within large protein complexes such as the nuclear cap-binding complex. The small nuclear cap-binding protein (NCBP) 2 (or CBP20) directly contacts mRNA via the cap structure (m7GpppG), while the larger NCBP1 (CBP80) interacts with NCBP2 (Mazza et al., 2002) . In agreement, RBDmap defines the RNA-binding region of NCBP2 within the m7GpppG-binding pocket and no RBDpep is assigned to the large NCBP1 ( Figure S3A ). Moreover, RBDmap defines the corresponding RNA-binding sites within NCBP2 (Mazza et al., 2002) and its cytoplasmic counterpart eIF4E (Brown et al., 2007) (Figure S3B ), in spite of their low sequence identity. The glutamyl-prolyl-tRNA synthetase (EPRS) represents a large non-canonical RBP that harbors two tRNA synthase domains separated by three WHEP motifs ( Figures S3C and S3D) . The first and second WHEP motif bind the GAIT RNA element present in the 3 0 UTRs of a number of pro-inflammatory mRNAs (Jia et al., 2008) , in complete agreement with the RBDmap data.
To test whether RNA-binding assignments of RBDmap can reach near single-amino acid resolution, we collected the complete set of RBDpeps and released peptides mapping to a given RBD class (e.g., RRM) and assessed their relative position within (legend continued on next page) the domain (from 0 to 1) as well as its adjacent upstream (from À1 to 0) and downstream regions (from 1 to 2) ( Figure 3B ). The MSidentified part (N-link) of each RBDpep was then subtracted to infer the RNA-crosslinked (X-link) moiety(s), which cannot be identified by conventional MS due to their nucleotide remnant ( Figures 1A and 3B ). The X-link/released peptide ratio was calculated for each position in the domain, where high prevalence of X-link over released peptides will indicate RNA binding (Figure 3B) . The high accuracy of this analysis is illustrated by the example profile obtained for RRMs. As shown in Figures 3C , 3D, and S3E, the highest X-link/released peptide ratio points to b strand 1, 2, and 3 as partners in the interaction with RNA, in agreement with the dozens of RNA-RRM co-structures available. Note that the LysC and ArgC proteases dissected the RRM in a differential manner: while LysC points to b strand 1 and 3, ArgC identifies b strand 2 as RNA-binding site, reflecting that the mapping capacity by these proteases depends on the distribution of lysines and arginines. Moreover, these data support the complementarity of the LysC and ArgC data sets to build accurate and comprehensive RNA-binding maps. Unexpectedly, we observed two discrete peaks of high X-link/released peptide ratio within the a helices placed at the back of the RRM. These peaks coincide with amino acids projected from the a helix to the RNA in several structures ( Figure S3F ) (Safaee et al., 2012; Teplova et al., 2010) and hence confirm the accuracy of RBDmap. This analysis also successfully assigned correct RNA-binding sites to KH, DEAD-box helicase, and CSD, as shown in Figures  3E-3J , S3G, and S3H. The DEAD box helicase domain establishes interactions primarily with the phospho-sugar backbone of the RNA, while nucleotide bases project away from the protein core ( Figure S3I ). X-link peptide coverage of RBDmap for the DEAD box domain identifies one alpha helix in the helicase tunnel exit that coincides with the only position in RNA-protein co-crystals where multiple amino acids establish direct contacts with nucleotide bases. Interestingly, different binding orientations of the double-stranded RNA-binding motif (DSRM) have been observed in structural studies ( Figure S3J ) (Fu and Yuan, 2013; Ramos et al., 2000) . The X-link peptide coverage analysis of the DSRM domain highlights the loop separating the second and third b strands as interaction partners with the doublestranded RNA (Figures S3J and S3K) . Note that this loop is shown in several RNA-protein co-structures to be projected into the minor grove of the double-stranded RNA helix, establishing numerous interactions with the Watson-Crick paired bases (Lunde et al., 2007) . In summary, RBDmap faithfully re-identifies the protein surfaces of canonical RBDs that contact nucleotide bases.
Identification of Non-canonical RBDs
For more than half of the RBPs characterized by RBDmap, no functional or domain annotation related to RNA biology is currently available (Figures 1I and S1J ). RBDpeps identify dozens of unorthodox globular RBDs associated with different molecular functions, including DNA binding, enzymatic cores, mediators of protein-protein interactions, or of protein localization ( Figure 4A ; Table S2 ). As an illustrative example, thioredoxin (TXN) catalyzes disulfide bond formation and has recently been discovered in RNA interactomes (Beckmann et al., 2015; Castello et al., 2012) . RBDmap identifies an RBDpep at the N terminus of TXN ( Figure 4B ; Table S1 ) that overlaps with two solvent-exposed lysines (K3 and 8) highlighted as potential binding sites in the X-link coverage analysis for the TXN fold (Figures 4B and 4C) . To evaluate this assignment functionally, we expressed TXN-eGFP fusion proteins in HeLa cells. Following in vivo UV crosslinking, oligo(dT) capture, and stringent washes, green fluorescence in eluates was measured to quantify RNA binding ( Figure 4D ) (Castello et al., 2013b; Strein et al., 2014) . We used unfused eGFP as negative control and the well-established RNA-binding helicase MOV10 as a positive control for RNA binding (Gregersen et al., 2014) . Although all the fusion proteins are expressed at similar levels in cells, only TXN-eGFP and MOV10-YFP co-purify with poly(A) RNAs significantly above background ( Figure 4E ). Mutation of K3 and/or K8 to glutamic acid (E) totally abrogates TXN RNA-binding activity. Conversely, conservative mutation to arginine (R) is tolerated. These results experimentally validate the accurate identification of a previously unknown RNA-binding region by RBDmap.
We also noticed clusters of RBDpeps within enzymes. Peptidyl prolyl cis/trans isomerases are classified based on their domain architecture into two groups: PPI and FKBP. This protein superfamily has close links to RNA metabolism, and two members, PPIE and PPIL4, harbor classical RRMs (Mesa et al., 2008) . However, RNA interactome studies found 11 additional members of this family that lack RRMs as RBPs, suggesting the existence of a still unknown mechanism of RNA binding (Castello et al., 2012) . RBDmap reveals this RNA-binding activity within both the PPI and FKBP folds (Tables S1 and S2 ). Although lacking sufficient peptide coverage to perform an X-link peptide analysis, we noticed two clusters of RBDpeps at the N-and C-termini of the FKBP fold that are located far apart in primary sequence, but close in 3D structure ( Figures S4B and S4C ). The mapped candidate RBD opposes the catalytic site. Furthermore, we noticed clusters of RBDpeps in six chaperones of the heat shock protein (HSP) 90 and 70 families (Figure S4D ). HSPs are induced by cellular stress and prevent protein misfolding and subsequent aggregation, which typically occur in disordered regions of RBPs in health and disease (Weber and Brangwynne, 2012) . Indeed, HSPs have been functionally linked to RNA metabolism and translation (Iwasaki et al., 2010; Willmund et al., 2013) . Chaperone domain binding to RNA may help to increase the local concentration of the chaperone machinery at ribonucleoprotein complexes to avoid the accumulation of pathological aggregates.
Apparently, numerous enzymes of intermediary metabolism bind RNA through regions in close proximity to their substratebinding pockets. Specifically, the di-nucleotide binding domain (or Rossmann fold) and mono-nucleotide binding folds emerge as bona fide RBDs with 12 proteins mapped by RBDmap (Table  S3) , extending earlier observations (Cie sla, 2006; Nagy and Rigby, 1995) . RBDpeps mapping to Aldolase (ALDO) A and C delimit the fructose 1,6 bisphosphate interacting domain (Figures S4E and S4F) , suggesting that RNA and metabolite may compete for this binding pocket. Overall, the RBDpeps identified within metabolic enzymes show that the few well-characterized examples such as aconitase 1 (iron regulatory protein 1, IRP1), glyceraldehyde-3-phophate dehydrogenase, and thymidylate synthase may represent the tip of the iceberg of a more general engagement of metabolic enzymes with RNA (reviewed in Castello et al., 2015) .
RBDmap also uncovers RNA-binding activities within PDZ, 14-3-3, ERM, and the tubulin-binding domains, which are involved in protein-protein interactions and protein localization ( Figures 4F, 4G , and S4G-S4I). Due to the high peptide coverage of the PDZ domain, we could generate an X-link analysis (Figures 4F and 4G) . This map shows a discrete RNA-binding site within a basic cavity formed by a short a helix and two b strands.
RBDmap also identifies RNA-binding sites within domains of unknown function such as NDR and DZF. N-myc downstreamregulated genes (NDRGs) represent a family of proteins with unknown function. NDRG1 is a metastasis suppressor relevant for cancer progression and prognosis (Chang et al., 2014) , its exact molecular function has remained unknown. RBDmap resolves a conserved RNA-binding region within the NDR domain of NDRG1, NDRG2, and NDRG4. RBDpeps reproducibly map to the helix-loop-b strand structure at the C terminus of the NDR fold ( Figures S4J and S4K ). DZF is predicted to harbor nucleotidyltransferase activity (Kuchta et al., 2009) and to promote protein dimerization (Wolkowicz and Cook, 2012) . The X-link peptide coverage analysis maps the RNA-binding region to a deep, basic cleft between two symmetrical domain subunits ( Figures 4H and 4I) . The RNA-binding activity of the DZF domain is compatible with its proposed nucleotidyltransferase function.
To independently assess RNA-binding of PDZ and DZF domains, we used the T4 polynucleotide kinase (PNK) assay as an orthogonal approach. In brief, cells are irradiated with UV light and, after lysis, RNA is trimmed with RNase I. Proteins of interest are immunoprecipitated under stringent conditions and the presence of RNA revealed by 5 0 end phosphorylation with PNK and [g-32 P]-ATP, followed by SDS-PAGE and autoradiography. We generated Tet-inducible HeLa cell lines expressing the PDZ domain of b-1-syntrophin (SNTB) 1 and SNTB2, as well as the DZF domains of Zinc finger RNA-binding protein (ZFR) and interleukin enhancer-binding factor (ILF) 2 and ILF3, all fused to a FLAG-HA tag. As positive controls, we used the full-length ILF3 (FL), its DSRM domain alone, and hnRNPC, while actin (ACTB) was used as a negative control. The PNK assay shows radioactive bands of the expected molecular weight for all tagged PDZ and DFZ domains and only when UV light was applied to the cultured cells ( Figures 4J and 4K ). By contrast, no signal is detectable for the control ACTB. As expected, the DSRM domain of ILF3 also displays RNA-binding activity. Taken together, these data corroborate the RBDmap assignment of PDZ and DZF domains as RBDs. Even if functional studies will have to define the physiological roles of these unconventional RBDs in the future, their biological relevance warrants consideration. It is possible that these RBDs may endow RBPs with ''moonlighting'' activities in posttranscriptional regulation, akin to cytosolic aconitase (IRP1) (Muckenthaler et al., 2008) . Alternatively, the RBDs could serve as ''docking sites'' for regulatory or scaffolding RNAs that inhibit, activate, or modify protein functions. In analogy, innate immune effectors such as PKR, TLR3, TLR7, TLR8, or RIG-I, can be controlled by pathogen-derived RNAs (Barbalat et al., 2011; Yu and Levine, 2011) . RNA may also serve to recruit proteins to RNPs, akin to NEAT1 RNA in paraspeckle formation (Clemson et al., 2009) . The identification of these RBDs and the mapping of the RNA-interaction sites for hundreds of proteins serve as a Figure 2D (top). The ratio of the X-link over released peptide coverage at each position of the TXN fold as in Figure 3C is shown (middle). The secondary structure prediction for each position of the TXN fold and flanking regions is shown (bottom). See also Tables S2, S3 , and S5 and Figure S4 . critical step toward definition of the biological functions of these RBPs in detail.
Disordered Regions Emerge as Frequent RNA Interaction Sites In Vivo A high proportion of the human RBPs lack native 3D structure (Castello et al., 2012) , and these disordered regions can occasionally engage in non-canonical protein-RNA interactions (45 examples reviewed in Jä rvelin et al., 2016). In some instances, these interactions can induce co-folding of both molecules (Phan et al., 2011) . While this mode of interaction emerged recently, the scope of disordered motifs involved in RNA-binding remained unknown. Strikingly, half of the RBDpeps map to disordered regions, and RBDmap identifies a disordered RBD as the sole detectable RNA-binding site for 170 RBPs (Figures 5A 5B,, and S5A). Disordered RBDpeps largely mirror the chemical properties of the whole RBDpep superset, apart from the expected enrichment for disorder-promoting residues (proline [P], serine [S] , and glycine [G]), as well as R and glutamine (Q) (Figures 5C and S5B) .
Detailed analysis identifies clusters of disordered RBDpeps that can be classified on the basis of sequence motifs. While a few R-rich, RGG, and SR repeats have previously been shown to bind RNA experimentally (Jä rvelin et al., 2016) , RBDmap expands the RNA-binding role of these motifs by dozens of additional examples ( Figures 5D and S5C ). The superset of RNA-binding RGG boxes can be subclassified by the lengths of the glycine linkers (Thandapani et al., 2013) . Because glycines can position arginines and contribute to RNA binding providing shape complementarity, G-linker length could serve in setting the motif's specificity for RNA. In agreement, both arginine and glycine substitutions impair RGG-RNA recognition (Phan et al., 2011) .
Aromatic residues are typically found in hydrophobic cores. However, histidines (H), phenylalanines (F), and especially tyrosines (Y) occur within the RNA-binding disordered regions (Figures 5D and S5C) . YGG repeats (also called [G/S]Y[G/S]) can promote protein aggregation in vitro, inducing hydrogel formation and amyloid-like fibers, as well as dynamic phase transitions in vivo (Han et al., 2012; Kato et al., 2012) . Since YGG repeats are identified as a potential RNA-binding motif in our data set, it will be important to elucidate whether their RNAbinding capacity is affected by the aggregation state and, conversely, whether RNA-binding to such disordered linear motifs can affect phase transitions and granule formation (Zhang et al., 2015) .
Lysine (K) combines with negatively charged residues, G, P, or Q, to form distinctive RNA-binding motifs ( Figures 5D and S5C) . The stoichiometry and distances between lysines and other amino acids are similar across analogous K-rich motifs present in non-homologous proteins ( Figure 5E ). Several copies of a repeat combining basic and acidic residues within the neuroblast differentiation-associated protein AHNAK are identified by RBDmap (Figure S5D ), suggesting that low complexity regions can contribute to modular RNA-binding architectures, similar to globular RBDs. Interestingly, the K-rich regions within RBPs display similarities with the basic tails of DNA-binding proteins. The large capture radius of these disordered regions play important roles in transcription factor activity by favoring ''hopping'' and ''sliding'' over 3D diffusion to reach their target sequences (Vuzman et al., 2010) . K-rich sequences may play similar roles in RBPs.
To validate the disordered regions identified by RBDmap as bona fide RNA-binding motifs, we fused the RGG-rich and the K-rich sequences from FUS and Methyl-CpG-binding protein 2 (MECP2), respectively, to eGFP and tested the fusion proteins with the same assay as in Figure 4D : both short motifs suffice to confer RNA-binding to eGFP (Figures 5F and 5G) .
The biological function and mode of interaction of disordered regions with RNA should be further investigated.
Uncovering Biological Properties of RBDs
Previously unknown RNA-binding globular and disordered regions display similar mean isoelectric points as known RBDs ( Figure 6A ), while their released counterparts exhibit a significantly lower isoelectric point, as expected. Thus, (1) both previously unknown and well-characterized RBDs share common chemical properties, (2) they differ from released fragments, and (3) the unorthodox RBDs do not artificially associate with RNA due to an abnormally high isoelectric point. Established RBPs and proteins harboring previously unknown globular and disordered RBDs display very similar mRNA abundance profiles, ranging from low to high levels, with a slight tendency to lower abundance for the unconventional folded and disordered RNAbinding regions ( Figures 6B and 6C) . Thus, proteins with unorthodox RBDs are not biased toward high abundance. Notably, RBDpeps in both globular and disordered RBDs are more highly conserved throughout evolution than their released counterparts ( Figure 6D ), suggesting functional relevance.
Cross-referencing of the RBDpep data sets with databases of curated posttranslational modifications shows that RNA-binding sites represent hot spots for defined post-translational modifications (PTMs, p = 2.025 3 10 À08 ), including tyrosine phosphorylation, methylation, acetylation, and malonylation ( Figure 6E ). This finding suggests that, reminiscent of chromatin remodeling, RBDs are posttranslationally regulated and respond to signaling and metabolic cues. The conserved amino acid contexts of these PTMs implicate sequence-selective modifying enzymes ( Figure 6F ). Interestingly, acetylation frequently occurs in a lysine two positions upstream of a conserved proline ( Figure 6F ). Proline isomerization in the basic tail of histone H3 is regulated by acetylation of adjacent lysines and has notable consequences for protein conformation (Howe et al., 2014) . Our results suggest the possibility that this regulatory mechanism could also apply to RBP regulation.
Our data also show that Mendelian disease mutations cluster within RBDs compared to natural variants (p = 0.0001796) (Figure 6G ; Table S4 ). For example, one RBDpep maps to an RGG-box in FUS that is a hotspot for disease-associated mutations ( Figure 6H ) (Shang and Huang, 2016) , and the RNAbinding activity of this region is validated here by an orthogonal approach ( Figures 4D and 5G) . Interestingly, a mutation in this region (R495X) causes amyotrophic lateral sclerosis (ALS) and correlates with impaired interaction of FUS with the SMN complex and reduced localization to nuclear gems (Yamazaki et al., 2012) . The relationship between altered RNA-binding and disease phenotypes in this and other proteins deserves further exploration.
Conclusions
RBDmap provides an unprecedented identification of RNAbinding regions of RBPs in living cells. It describes 1,174 high confidence (1% FDR) RNA-binding sites within 529 proteins. These sites have been validated as a whole by stringent statistical analyses (Figure 1 ) and cross-correlation with well-established RBPs and domains, previously studied by biochemical and structural means (Figures 2 and 3) . We also validated a small number of previously unknown RBDs (TXN, PDZ, DZF, and the Table S4. disordered regions of MECP2 and FUS) individually, applying orthogonal methods (Figures 4 and 5) . Against this background, we recommend similar validation experiments for any individual RBD of interest before further in depth analyses. Our data suggest that multifunctional globular domains, which combine RNA-binding with enzymatic functions or protein-protein interaction surfaces, are commonplace, not rare exceptions. These invoke additional functions for RNA, including the (allosteric or competitive) control of catalytic activities and of protein-protein interactions. Moreover, disordered regions are found to play common roles in native protein-RNA interactions, comprising half of the total RNA-binding sites identified.
The RNA-binding motifs identified here share physico-chemical features of well-established RBDs, are conserved across evolution, and represent hot spots for posttranslational modifications and disease-associated mutations. Individually and in combination, these features suggest important biological roles.
As a method, RBDmap can now be applied to other cell types and organisms such as S. cerevisiae, Caenorhabditis elegans, or Drosophila melanogaster to study the evolution of RBDs. It can also be applied to cells subjected to different experimental conditions to investigate the responses of RBPs to physiological cues such as e.g., stress, starvation, or differentiation.
EXPERIMENTAL PROCEDURES RBDmap
Initial UV crosslinking and oligo(dT) purification followed the mRNA interactome capture protocol (Castello et al., 2013b) . Complete proteolytic digestions were performed with LysC or ArgC for 8 hr at 37 C. Polyadenylated RNA and crosslinked peptides were diluted in 20 mM Tris-HCl, 500 mM LiCl, 1 mM DTT, and 0.5 mM EDTA and recaptured on oligo(dT) beads. The supernatant was processed for MS (released peptides). oligo(dT) beads were washed as in Castello et al. (2013b) . All fractions were treated with trypsin and labeled with stable isotopes in vitro (Boersema et al., 2008) . Peptides were analyzed on a liquid chromatography-tandem MS (LC-MS/MS) platform. The R-scripts used for the analyses can be found in the R/Bioconductor data-package RBDmapHeLa (http://www.bioconductor.org). RBDmap data can be accessed under http:// www-huber.embl.de/users/befische/RBDmap.
MS, Protein Identification, and Quantification
Proteins were processed following standard protocols, and the resulting peptides were labeled with stable isotopes in vitro, fractionated, and analyzed on a nano-HPLC system (Proxeon) or nano-Acquity UPLC system (Waters) coupled directly to an LTQ Orbitrap Velos (Thermo Fisher Scientific).
Data Analysis
A complete description of data analysis can be found in the Supplemental Information.
Fluorescence-Based Method to Measure RNA-Binding In Vivo and PNK Assay Tet-on HeLa cells expressing eGFP fusion proteins were generated as described elsewhere (Castello et al., 2012) . Upon induction, cells were UV irradiated and subjected to small scale RNA interactome capture (Castello et al., 2013b) . Eluates were measured in a plate reader. For PNK assays, cell monolayers were irradiated with 150 mJ/cm2 UV 254 (Castello et al., 2013b) . After cell lysis and RNase treatment, FLAG-HA tagged proteins were immunoprecipitated with an anti-FLAG antibody coupled to magnetic beads (M8823, Sigma Aldrich) and processed as in Beckmann et al. (2015) . More detailed information can be found in the Supplemental Information.
ACCESSION NUMBERS
The accession number for the proteomics data reported in this paper is ProteomeXchange Consortium (http://www.proteomexchange.org): PXD000883. Kato, M., Han, T.W., Xie, S., Shi, K., Du, X., Wu, L.C., Mirzaei, H., Goldsmith, E.J., Longgood, J., Pei, J., et al. (2012) . Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Table S1 . A) Western blot against ACTB, PTBP1 and hnRNPQ/R using whole cell lysates of UV 254 irradiated and non-irradiated HeLa cells from three independent biological replicates. B) Computational simulation of protease efficiencies in RBDmap experiments. The RBPs of the HeLa mRNA interactome (Castello et al., 2012) were digested in silico using the different proteases available for MS experiments. The peptides identified in (Castello et al., 2012) were used as a proxy for protein coverage of an RBDmap experiment performed with the same cell line. We then selected the peptides that do not span the cleavage sites predicted for each protease and assumed the existence of the putative RNA-binding site at the centre of each RBP to calculate the best theoretical RBD resolution associated with each protease. The fractural number of proteins mapped for which the RBD was resolved to at least 20% of the actual protein length is represented. C) RNA integrity analysis under different LysC digestion conditions of oligo(dT)-purified samples (input). Samples were treated with proteinase K and monitored by bioanalyser. D) RNA analysis using bioanalyser of a representative LysC RBDmap experiment. E) Protein quality control of two independent experiments using ArgC. Poly(A) RNA extracted from UV irradiated (CL) and non-irradiated (noCL) cells was purified by oligo(dT) selection. Co-purified proteins were treated with 1µg of ArgC and analysed by silver staining prior to and after protease digestion. Optimization of LysC digestion of UV-irradiated oligo(dT) purified samples (input) applying different protease concentrations, incubation times and temperatures. F) Scatter plots comparing the peptide intensity ratios between RNA-bound and released fractions of three independent LysC and ArgC experiments. The peptides enriched in the RNA-bound over the released fraction at 1% and 10% FDR, respectively, are shown in red and salmon. G) Venn diagram comparing LysC and ArgC datasets at the peptide or protein level at 1% FDR. H) Density of mRNA levels of the whole HeLa proteome (red), the HeLa RNA interactome (Castello et al., 2012) (blue), the input sample (i.e. equivalent to the HeLa mRNA interactome -green), and proteins assigned with at least one 1% FDR RNAbinding site by RBDmap (purple). I) Scatter plot comparing the average peptide intensity ratios from three biological replicates between UV irradiated and non-irradiated samples (X axis) and between RNA-bound and released fractions (Y axis). Red represents RBDpeps (1% FDR) belonging to newly discovered proteins, while yellow peptides represent the rest of RBDpeps. J) Number of proteins annotated with the GO term RNA-binding, with a GO term related to RNA, or with an annotation unrelated to RNA in the HeLa mRNA interactome (left) and in RBDmap datasets (right). Table S2 . A) Enrichment of peptide trimers in RNA-bound (X axis) and released (Y axis) proteolytic fragments. In salmon and blue are the most abundant trimers in RNA-bound or released fractions. B-D) LysC and ArgC proteolytic fragment distribution of an illustrative KH-domain (B), DEAD box-(C) or AAA_11/AAA_12-(D) containing RBP. X axes represent proteins from N-to C-termini, while the Y axes show the RNA-bound/released peptide intensity ratios. Positions of the protein domains are shown in boxes under the X axis. E) The RBDpep (red) conserved between EIF4A1 and EIF4A2 was placed in the structure of their homolog EIF4A3 (light grey), which was crystalized in a complex with MAGOH, Y14 and barentz (dark grey) forming the exon junction complex (EJC, PDB 2j0s) (Bono et al., 2006) . This region is highly conserved between the three homologs (EIF4A3 LDYGQ-HVVAGTPGRVFD-MIRRRSLRTR; EIF4A1, LQMEAPHIIVGTPGRVFDMLNRRYLSPK EIF4A2 LQAEAPHIVVGTPGRVFDMLNRRYLSPK) and is placed at the exit of the RNA tunnel (left panel). Right panel shows the RBDpeps (red) within UPF1, projected in the crystal structure of UPF1 with RNA (PDB 2xzo) (Chakrabarti et al., 2011) . A) Crystal structure of the nuclear cap-binding complex bound to the cap structure (PDB 1h2t) (Mazza et al., 2001) . NCBP2 is depicted in grey and NCBP1 in gold. RBDpeps are shown in red. B) Location of the RBDpep in NCBP2 (PDB 1h2t) (Mazza et al., 2001 ) and its cytoplasmic homolog EIF4E (PDB 2v8x). C) Schematic representation of the reported interaction mechanism of EPRS with mRNAv (Jia et al., 2008) . D) The RBDpep distribution of the EPRS protein matches the biochemical and functional data reported in (Arif et al., 2009; Jia et al., 2008; Mukhopadhyay et al., 2008) . E) X axis represents the relative position of the RRM (from 0 to 1) and their upstream (-1 to 0) and downstream (1 to 2) regions. The ratio of the X-link over released peptides at each position of the RRM and surrounding regions using the ArgC dataset was computed and plotted (top). Secondary structure prediction for each position of the RRM and flanking regions (bottom). F) Crystal structures showing the interaction of amino acids in the α-helices of the RRM with the RNA (PDBs 4f02, 3nnc, 2l41 ). These structures agree with the LysC X-link coverage analysis in Figure 3C . G) As in (E) but for DEAD box domain. H) As in (E) but for KH1. I) Detail of eIF4A3 (DEAD-box) interacting with RNA (PDB 2j0s). RNA is shown in pale yellow, except for the ribonucleotides that are contacted by amino acids projected from the DEAD-box domain, which are shown in magenta. The protein region enriched in the X-link peptide coverage analysis is shown in red. J) The ratio of X-link over released peptides was plotted for two structures in which the DSRM domain is bound to double stranded RNA in different orientations (PDBs 3vyx, 3adl) using a heat map color code. K) As in (E) but for DSRM.
SUPPLEMENTAL INFORMATION
Figure S4 (FKBP1A, FKBP2, FKBP3 ). C) Crystal structure of FKBP1 bound to a synthetic ligand (PDB 1bl4). The electrostatic potential of the protein surface is shown in blue for basic and red for acidic surfaces. D) As in (B) but for HSP90 (top) and HSP70 (bottom) protein family members. E) As in (B), but for aldolase A and C. F) Ribbon diagram of ALDOA (top), where amino acids involved in the interaction with fructose 1,6 bisphosphate are shown as spheres (PDB 2ld). RBDpeps are shown in red. The electrostatic potential of the protein surface is shown in the bottom panel (blue, basic; red, acidic). G) As in (B) but for 14-3-3 and ERM protein families. H, I and K) Ribbon diagrams and the electrostatic potential of ERM (H), 14-3-3 (I) and Ndr (K) using homology models generated with Phyre2 (Kelley and Sternberg, 2009) . J) As (B) but for NDRG protein family. Table S1 . Related to Figure 1 and Figure S1 . List of RBDs and their respective peptides, identified by RBDmap. Table S4 . Related to Figure 6 . Mendelian mutations occurring within the RNA-bound fragments of RBPs and their associated diseases.
ADDITIONAL FIGURE LEGENDS
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Considerations regarding the design of RBDmap
RBDmap was designed to offer the following advances over existing methods: 1) identification of the domains of RBPs engaged with RNA in living cells, offering high-resolution RBD maps. 2) Characterization of hundreds of RBPs on a proteome-wide scale, providing the capacity for RBD "discovery" from both well-established RBPs and proteins previously unrelated to RNA. RBDmap scores endogenous protein-RNA interactions in a physiological context, since native protein-RNA pairs are covalently linked upon irradiation of cell monolayers. Note that UV crosslinking can only occur between nucleotides and amino acids in direct contact. In contrast to chemical crosslinking, UV crosslinking does not promote detectable protein-protein crosslinks ( Figure S1A , Figure S4A ) (Castello et al., 2013b; Pashev et al., 1991; Strein et al., 2014) . 3) Protein-RNA co-structures greatly contributed to understanding protein-RNA interactions mediated by globular protein domains. Conversely, disordered domains represent a challenge for crystallization approaches. Because RBDmap can define RBDs within both globular and disordered regions, it complements structural studies. Moreover, RBDmap can be used to instruct CLIP-seq approaches by providing the RNA-binding profiles for many RBPs of interest. 4) RBDmap is here applied to steady state cell cultures, but it can be used to study in a system-wide manner the plasticity of RBDs in response to physiological alterations. 5) RBDmap further validates hundreds of novel RBPs discovered by human RNA interactome studies ( Figure 1G ) (Baltz et al., 2012; Castello et al., 2012) and assigns them a RNA-protein interface. It is important to highlight that the buffers used here include high salt (500 mM LiCl) and chaotropic detergents (0.5% LiDS) that efficiently remove noncovalent binders from purified RNA (Baltz et al., 2012; Castello et al., 2012; Castello et al., 2013b) , as illustrated by the low protein content present in non-irradiated samples . RBDmap applies protease digestion to identify RBDs. This generates peptides of ~17 amino acids ( Figure 1A ), disrupting proteinprotein interactions that might have withstood the stringent washing conditions. Note that RBDmap does not cover all the proteins identified by RNA interactome capture ( Figure 1G ). Although experimentally related, RNA interactome capture and RBDmap differ in key aspects that may affect peptide identification by MS. Compared to RNA interactome capture, RBDmap includes a protease (LysC or ArgC) treatment prior to a second oligo(dT) purification step, as described above ( Figure 1A ). These additional steps reduce sample complexity and background level, facilitating the identification of additional peptides ( Figure 1H ). On the other hand, RBDmap may fail to assign RNA-binding sites to a number of proteins detected by RNA interactome capture for the following reasons: 1) LysC/ArgC treatment can impair peptide identification when the resulting RNA-bound peptide is identical to the tryptic peptide and no "neighboring" MS-detectable peptide can be released after trypsin treatment. Due to the frequent occurrence of arginines and lysines in RBPs, these cases may not be infrequent.
2) The two-round purification workflow of RBDmap causes increased material loss compared to RNA interactome capture and, indeed, we find that RNA recovery is reduced to about 60%. Therefore, the reduction in background described above is also accompanied with a decrease in signal. 3) We apply highly stringent statistical criteria to report a peptide as an RBDpep. The coverage of the HeLa RNA interactome would be much higher if "CandidateRBDpeps" [10% false discovery rate (FDR) instead of 1% FDR] would also be considered. Taking this set of peptides into account, RBDmap would cover most of the RBPs reported in the HeLa RNA interactome. However, to minimize the incidence of wrongly assigned RBDs (false positives), we opted to apply highly stringent 1% FDR cut-off. Since "candidateRBDpeps" could provide valuable information, this dataset is accessible in Table S1 and online (http://www-huber.embl.de/users/befische/RBDmap).
Selection of the first protease for RBDmap
An in silico digest of all protein sequences of the HeLa mRNA interactome (Castello et al., 2012) provided a set of theoretical proteolytic fragments for each of the eleven proteases commonly used in proteomics. Tryptic peptides identified in the HeLa mRNA interactome were mapped onto the proteolytic fragments predicted for each protease. We set a theoretical RNA-binding site in the center of the protein and monitored the number of cases where the protease fragment covers the theoretical binding site. The
RBDmap resolution for each protease was determined as the number of proteins for which a given protease can narrow down the RNA-binding site to less than 20% of the actual protein length. LysC and ArgC were identified as the proteases that theoretically would perform better in a higher number of proteins of the HeLa RNA interactome. However, other proteases may outcompete LysC and ArgC in a case-dependent manner.
The RBDmap protocol
HeLa cells were grown overnight on six 500cm 2 dishes in DMEM medium supplemented with 10% fetal calf serum. Three of the plates were incubated overnight with 100 μM 4-thiouridine (4SU) for PAR-CL. After PBS wash, 0.15 J/cm 2 UV light at 254nm (for cCL) was applied on untreated cell monolayers (3 dishes) and 365nm (for PAR-CL) on 4SU-treated cell monolayers (3 dishes), as previously described (Castello et al., 2013b) . Cells were harvested and lysed in a buffer containing 20mM pH 7.5 Tris HCl, 500mM LiCl, 0.5% LiDS, 1mM EDTA and 5 mM DTT and homogenized by passing the sample through a syringe with a narrow gauge needle (0.4 mm diameter). Proteins crosslinked to poly(A) + mRNAs were captured with oligo(dT) 25 magnetic beads (NE Biolabs). Subsequently, oligo(dT) 25 beads were washed with buffers containing decreasing concentrations of LiCl and LiDS, as previously described (Castello et al., 2013b) . RNAs and crosslinked proteins were eluted with 20mM Tris HCl, pH 7.5 at 55 o C for 3 min. 70 µl were taken for RNA and protein quality controls as previously described (Castello et al., 2013b) . For RNA analysis, samples were digested with proteinase K, followed by RNA isolation with RNeasy (Qiagen). The remaining sample was treated with 1µg of LysC or ArgC, and supplemented with 1 µl of RNaseOUT (Promega) and 5x of the protease buffer as described by the manufacturer. After digestion at 37 o C for 8h, 70 µl were taken for RNA and protein quality controls as described (Castello et al., 2013b) . 1/3 of the sample from irradiated and non-irradiated cells was taken for mass spectrometry (input) and processed as indicated below. The rest of the sample was diluted 2 ml of 5x dilution buffer (2.5 M LiCl, 100mM pH 7.5 Tris HCl, 5 mM EDTA and 25 mM DTT) and H 2 O (10 ml total volume), and incubated with 2 ml of oligo(dT) beads for 1 h. After separating the beads with a magnet, the supernatant was collected and kept at 4 o C (released fraction). Beads are washed once with 500mM LiCl and 0.5% LiDS containing buffer, and with buffers containing decreasing concentrations of LiCl and LiDS as previously described (Castello et al., 2013b) . The RNA-bound fraction is eluted with 20mM Tris HCl, pH 7.5 for 3 min at 55 o C. All input, supernatant (released) and eluates (RNA-bound) are treated with RNase T1 and RNase A (Sigma). Samples were then processed for MS as described below.
